Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Heart Transplants From Hepatitis C-Positive Donors
Latest Information Update: 06 May 2022
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms USHER
- 11 Feb 2020 Status changed from active, no longer recruiting to completed.
- 29 Oct 2019 Planned End Date changed from 1 Dec 2020 to 1 Nov 2019.
- 29 Oct 2019 Status changed from recruiting to active, no longer recruiting.